The global Real-Time Polymerase Chain Reaction Market size was USD 4.64 Billion in 2021 and is expected to register a revenue CAGR of 7.8% over the forecast period, according to the latest report by Reports and Data. Increasing adoption of qPCR in medical diagnosis and new product launches are key factors driving market revenue growth. In addition, rising cases of chronic diseases, such as cancer, hepatitis, Human Immunodeficiency Virus (HIV), and many others, are also driving market revenue growth. For instance, according to World Health Organization (WHO), an estimated 354 million people living worldwide live with hepatitis C or hepatitis B. By 2030, hepatitis-related premature deaths in low- and middle-income countries might be reduced by an estimated 4.5 million owing to treatment kits such as qPCR, medications, and others.

Other factors influencing the growth of the qPCR market revenue include recent technological developments, research expenditures, and the introduction of new products. For example, Azure Biosystems, a supplier of cutting-edge bioanalytical solutions for protein and cell biology, said on October 27, 2021, that it would offer Azure Cielo Dx in the European Union (EU) for use in in vitro diagnostics (IVD). Real-time PCR systems Azure Cielo 3 Dx and Azure Cielo 6 Dx, which support three- and six-channel nucleic acid detection, respectively, comply with the EU's In Vitro Diagnostic Directive (IVDD). Simple software and a 10.3" touch screen interface make it easy to start up, run, and check the instrument's run status. Moreover, data transfer by USB, ethernet, and Wi-Fi is supported by the little gadget. The system has Azure Cielo in it.

Request Free Sample Copy @ https://www.reportsanddata.com/download-free-sample/5500

Some Key Highlights From the Report

• On 9 November 2020, Streck, headquartered in the U.S., which develops and manufactures products in hematology, immunology, molecular diagnostics, cell stabilization, infectious diseases, and urinalysis for clinical and research laboratories announced to launch Zulu RT, which is a rapid, modular qPCR instrument capable of performing four independent experiments simultaneously. It can complete a 40-cycle, 6-channel, 3-step real-time PCR in less than 20 minutes. In addition, Zulu RT combines exclusive, proprietary thermal technology from Streck with potent optics. Moreover, it can do rapid, six-color detection faster than any other conventional instrument and has excellent thermal management.
• The reagents and consumables segment accounted for largest revenue share in 2021. This is due to affordability of core kits when compared to master mixes, freedom to design customized reaction protocols, expansion of private and public funding for life science research, and expansion of market accessibility of qPCR kits in developed countries.
• The blood and oncology segment accounted for largest revenue share in 2021 due to increasing adoption of infectious and genetic disorders such as hepatitis, HIV, and cancer. According to HIV.gov, In 2021, 85% of all HIV-positive individuals knew that they have HIV. HIV testing is a key entry point for HIV prevention, care, treatment, and support services.
• The North America market accounted for largest revenue share in 2021. Increasing investments in healthcare and launch of new products are major factors driving market revenue growth. The U.S. is expected to lead regional demand owing to the presence of market participants such as Abbott, Thermo Fisher Scientific, Agilent Technologies, and many others. In addition, increased penetration of qPCR in diagnosing infectious diseases, such as HIV, malaria, and others, is driving market revenue growth.

Key Players covered in this report are

Abbott, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, F. Hoffman-La Roche Ltd, BD, Agilent Technologies Inc., Integrated DNA Technologies Inc., Standard BioTools, Takara Bio Inc., and Lumex Instruments.

Product Type Outlook (Revenue, USD Billion; 2019–2030)

• Reagents and Consumables
• Instruments
• Software and Services

Application Outlook (Revenue, USD Billion; 2019–2030)

• Blood and Oncology Testing
• Pathogen Testing
• Research and Development
• Forensic Testing
• Others

End-Use Outlook (Revenue, USD Billion; 2019–2030)

• Hospitals
• Research Laboratories and Academic Institutes
• Diagnostic Centers
• Clinical Research Organizations (CROs)
• Forensic Laboratories
• Pharma and Biotech Companies
• Others

Geographic Segment Covered in the Report:

The Real-Time Polymerase Chain Reaction report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Real-Time Polymerase Chain Reaction industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Real-Time Polymerase Chain Reaction Market report provides key statistics on the market status of the Real-Time Polymerase Chain Reaction manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/5500

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Semiconductor Laser Therapeutic Equipment Market @ https://www.reportsanddata.com/report-detail/semiconductor-laser-therapeutic-equipment-market

Sepsis Market @ https://www.reportsanddata.com/report-detail/sepsis-market

Septic Shock Market @ https://www.reportsanddata.com/report-detail/septic-shock-market

Trimellitic Anhydride Market @ https://www.reportsanddata.com/report-detail/trimellitic-anhydride-market

https://www.mcb.com.pk/?URL=https://www.reportsanddata.com/

https://www.ticrecruitment.com/?URL=https://www.reportsanddata.com/

https://www.altoprofessional.com/?URL=https://www.reportsanddata.com/

https://www.montshire.org/?URL=https://www.reportsanddata.com/

https://onecallcm.com/?URL=https://www.reportsanddata.com/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]